PIK3CA and angioosteohypertrophic syndrome: Researchers have recently identified activating mutations in PIK3CA in isolated LMs as well as overgrowth syndromes such as KTS and CLOVES syndrome, and collectively termed these diseases PIK3CA-related overgrowth spectrum (PROS) [9].